G1 is committed to improving the lives of those impacted by cancer.
Led by a team with a deep understanding of the biology of cancer and extensive development and commercialization expertise, G1 is advancing its mission to improve the lives of those affected by cancer, including by commercializing the Company’s first product. G1 is also executing a development program, with late-stage clinical trials ongoing in multiple tumor types including breast and bladder cancers, and in trials designed to inform the design of future additional pivotal studies across multiple tumor types and treatment combinations.
